Skip to main content
. 2021 Aug 31;20(19):2021–2039. doi: 10.1080/15384101.2021.1965723

Figure 1.

Figure 1.

The expression of circLNPEP in ovarian cancer and the stability of circLNPEP

(a-b) Overall survival and progression-free survival curves. Patients with high circLNPEP expression levels exhibited a poor prognosis.(c) CircLNPEP expression in ANT and cancer tissues was detected by qRT-PCR.P < 0.001. (D) CircLNPEP expression in human normal ovarian epithelial cell line and ovarian cancer cell lines was examined by qRT-PCR. (e) qRT-PCR analysis of circLNPEP and LNPEP mRNA after treatment with RNase R. (f-g) The abundance of circLNPEP and LNPEP mRNA was assessed by qRT-PCR treated with Actinomycin D at the indicated time points. Quantified values were expressed as mean ± standard deviation. Experiments were conducted independently in triplicate. GAPDH was used as internal control. ***P < 0.001 vs IOSE80 group. ^^^P < 0.001 vs RNase R group. ###P < 0.001 vs circLNPEP group.LNPEP: leucyl and cystinyl aminopeptidase. ANT: adjacent tissues. qRT-PCR: quantitative reverse transcription polymerase chain reaction. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.